New combo aims to shrink bile duct tumors before surgery
NCT ID NCT07267078
First seen Dec 18, 2025 · Last updated May 15, 2026 · Updated 17 times
Summary
This study tests whether adding two immunotherapy drugs (tuvonralimab and iparomlimab) to standard chemotherapy before surgery can help people with bile duct or gallbladder cancer. About 45 adults with tumors that can be surgically removed will receive 2-4 cycles of the combination, then undergo surgery. Researchers want to see if this approach leads to more complete tumor removal and better long-term outcomes without increasing complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.